top of page

Grants and Publications

Individualized Dosing of Therapeutic Monoclonal Antibodies:

A Changing Treatment 


Identification of Peptide Mimotope Ligands for Natalizumab

A Phase I Study of Escalated dose subcutaneous Alemtuzumab given weekly with Rituximab in Relapsed chronic Lymphocytic leukemia/Small Lymphocytic Lymphoma

A General Process for the Development of Peptide-based Immunoassays for Monoclonal Antibodies

bottom of page